Barbara Zeughauser had lost so many relatives to cancer: Her mother, her uncle, her grandmother, her second cousin. She thought that ghost in the family line might come after her, too. So in 2009, Zeughauser took a test offered by Myriad Genetics. It analyzed her DNA for mutations in the BRCA1 and BRCA2 genes that can make cancer more likely than not, raising the lifetime risk of breastcancer in women to between 55 and 85 percent, and to between 10 and 70 percent for ovariancancer.
Zeughauser was lucky and unlucky. She got a clear, unambiguous, and accurate answer from the test: She had a bad mutation. But she’d found it before she got cancer. She decided to have her ovaries removed and later had a double mastectomy, reducing her risk to almost average.
Her cousin Ken Deutsch wasn’t so lucky. In 2014, he was hit with bladder cancer. He also went...
“Humanity is dying,” billionaire Elon Musk told Fox News anchor Bret Baier recently when asked what keeps him up at night. “The birth rate is very low in almost every...
The Trump administration reportedly has plans to scrape your private medical data from sources like your doctor, your pharmacy, your insurance company, the lab that processes your bloodwork, your smartwatch, and your fitness apps—to create a “registry” of people with...
Last week Robert F. Kennedy Jr. held his first news briefing as secretary of the Department of Health and Human Services, to address a new report from...
The Center for Genetics and Society is fiscally sponsored by Tides Center, a 501(c)(3) non-profit organization.
Please visit www.tides.org/state-nonprofit-disclosures for additional information.
